글로벌 분자 분광법 시장 규모, 점유율 및 추세 분석 보고서 – 산업 개요 및 2031년까지의 예측

분자 분광법 시장 분석

분자 분광학 시장은 제약 , 의료 및 환경 테스트 와 같은 산업에서 빠른 기술 개선과 수요 증가로 인해 빠르게 확장되고 있습니다 . 시장 성장은 분석 정밀도와 기능을 변형시킨 향상된 근적외선(NIR) 및 라만 분광학 기술과 같은 발전에 의해 주도되고 있습니다. 이러한 발전으로 분자 분석이 보다 정확하고 효율적이 되어 제약 산업의 약물 개발 및 품질 관리부터 의료의 정교한 진단 도구에 이르기까지 광범위한 응용 분야가 용이해졌습니다.

분자 분광법 시장 규모

글로벌 분자 분광법 시장 규모는 2023년에 774만 달러로 평가되었으며, 2031년까지 1,361만 달러에 도달할 것으로 예상되며, 2024년에서 2031년까지의 예측 기간 동안 CAGR은 7.3%입니다. Data Bridge Market Research에서 큐레이팅한 시장 보고서에는 시장 가치, 성장률, 세분화, 지리적 범위, 주요 업체와 같은 시장 시나리오에 대한 통찰력 외에도 심층 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크도 포함됩니다.

분자 분광법 시장 동향

"환경 기준 개선에 더욱 집중"

환경 기준을 개선하려는 전 세계적인 초점과 정확하고 신뢰할 수 있는 테스트 절차에 대한 수요는 분자 분광학 시장의 성장을 견인하고 있습니다. 분자 분광학, 특히 라만 및 근적외선(NIR) 분광학은 공기, 물 및 토양의 오염 물질을 식별하고 측정하는 데 중요한 역할을 합니다. 예를 들어, 라만 분광학은 화학 오염 물질을 식별하고 실시간으로 수질을 모니터링하여 환경 규정 준수를 위한 중요한 데이터를 제공하는 데 널리 사용됩니다. 여러 부문의 이해 관계자가 규제 요구 사항을 충족하고 환경 문제를 관리하기 위한 고급 분석 솔루션을 모색함에 따라 분자 분광학 시장이 더욱 확대되고 있습니다.

보고서 범위 및 분자 분광 시장 세분화     

분자 분광법 시장 정의

분자 분광학은 전자기파와 분자 간의 상호 작용을 연구하는 분광학의 한 분야입니다. 분자가 다양한 파장에서 빛을 흡수, 방출 또는 산란하는 방식에 초점을 맞춰 구조, 구성 및 거동에 대한 자세한 정보를 제공합니다. 이러한 상호 작용을 분석함으로써 분자 분광학은 분자 특성을 식별하고, 물질을 특성화하고, 다양한 화학 과정을 이해하는 데 도움이 됩니다.

분자 분광법 시장 역학

운전자

• 제약 분야에서 분자 분광학에 대한 수요 증가

The pharmaceutical industry relies heavily on molecular spectroscopy for drug development, quality control, and regulatory compliance. For instance, Raman spectroscopy is used to analyze the molecular composition of drug formulations, ensuring the correct drug compound and verifying its stability over time. This technique helps identify and quantify active pharmaceutical ingredients (APIs) and excipients, ensuring that formulations meet strict regulatory standards and maintain consistent quality. Such demand for rigorous analytical methods in drug development and manufacturing propels the growth of the molecular spectroscopy market.

• Rising Use in the Biotechnology Industry

The increasing utilization of molecular spectroscopy in the biotechnology industries is significantly boosting the market's growth rate. For instance, the Thermo Fisher Scientific Q Exactive HF-X Mass Spectrometer is widely used in pharmaceutical research for its high-resolution capabilities, enabling precise identification of complex drug molecules and metabolites. In biotechnology, molecular spectroscopy aids in the characterization of biomolecules and the optimization of bioprocesses. Such growing reliance on advanced spectroscopic techniques reflects a broader trend towards more sophisticated analytical methods, driving substantial growth in the molecular spectroscopy market.

Opportunities

• Research and Development Investments

Increased investments in R&D across sectors such as materials science, nanotechnology, and chemical engineering are significantly fueling the demand for advanced spectroscopy tools, presenting a substantial opportunity for the molecular spectroscopy market. For instance, Wipro GE Healthcare has announced a USD 960 million investment in its manufacturing and R&D facilities in India, underscoring the growing emphasis on developing sophisticated analytical technologies. This investment reflects a broader trend where major players are channelling substantial resources into enhancing their capabilities, driving advancements in molecular spectroscopy.

• Advancements in Spectroscopy Technology

Innovations such as the integration of machine learning algorithms with molecular spectroscopy are transforming data analysis and interpretation, leading to significant advancements in the field. By applying machine learning techniques to spectral data, researchers can achieve more precise and automated analysis, reducing the time and complexity traditionally associated with data interpretation. For instance, machine learning algorithms can identify subtle spectral patterns and correlations that might be missed by manual analysis, enhancing the accuracy of Fourier-transform infrared (FTIR) and Raman spectroscopy. Such synergy streamlines the process and also increases the efficiency and value of these techniques across diverse applications, such as material science and pharmaceuticals. As a result, the combination of machine learning with molecular spectroscopy represents a transformative opportunity for advancing research and development across multiple industries.

Restraints/Challenges

• Stringent regulations

In Japan, the Pharmaceuticals and Medical Devices Agency (PMDA) imposes stringent regulations on molecular spectroscopy equipment used in pharmaceutical applications, such as those outlined in the Pharmaceutical Affairs Law (PAL) and the Good Manufacturing Practice (GMP) guidelines. Compliance with PMDA guidelines requires extensive validation procedures, detailed documentation, and adherence to specific quality standards for molecular spectroscopy. For instance, spectroscopy devices must undergo rigorous testing to ensure they meet the accuracy and reliability standards set forth by the PMDA. Such regulations mandate thorough performance validation, including detailed calibration and verification processes, which can lead to substantial additional costs and administrative efforts for manufacturers.

• High Cost Of Spectroscopy Instruments

The initial investment required for advanced systems, such as high-resolution FTIR or NMR spectrometers, can be prohibitively expensive. These sophisticated instruments, essential for precise and reliable molecular analysis, often come with high costs that may restrict spectroscopy instruments accessibility, particularly for smaller laboratories, research institutions, and organizations with constrained budgets. Such financial barriers can slow down the adoption of cutting-edge spectroscopy technologies and hinder their integration into broader research and industrial applications. Consequently, the high cost of equipment can restrict market growth by narrowing the pool of potential users and slowing the advancement of new technologies.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Molecular Spectroscopy Market Scope

The market is segmented on the basis of technology, and application. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Technology

• Nuclear Magnetic Resonance Spectroscopy
• UV-Visible Spectroscopy
• Infrared Spectroscopy
  • Mid-Wave Infrared Spectroscopy
  • Short-Wave Infrared Spectroscopy
  • Far-Wave Infrared Spectroscopy
  • Benchtop
  • Infrared Microscopy
  • Portable & Handheld
  • Hyphenated
  • Terahertz
• Near-Infrared Spectroscopy
  • Scanning Near-Infrared Spectroscopy
  • Fourier-Transform Near-Infrared Spectroscopy
  • Filter-Nir Spectroscopy/Acoustic-Optical Tunable Filter-Nir Spectroscopy
• Colour Measurement Spectroscopy
• Raman Spectroscopy
  • Surface-Enhanced Raman Scattering
  • Tip-Enhanced Raman Scattering
  • Micro-Raman Spectroscopy
  • Probe-Based Raman Spectroscopy
  • Ft-Raman Spectroscopy
• Other Technologies

Application

• Pharmaceutical Applications
• Food and Beverage Testing
• Biotechnology and Biopharmaceutical Applications
• Environmental Testing
• Academic Research
• Other Applications

Molecular Spectroscopy Market Regional Analysis

The market is analysed and market size insights and trends are provided by country, technology, and application.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America leads the global molecular spectroscopy market due to its robust healthcare infrastructure, the significant presence of key industry players, and a large patient population seeking advanced cancer diagnostics. The regions strong base of healthcare facilities further supports its dominance, while ongoing investments in research and development drive continued innovation and growth.

Asia-Pacific is projected to experience substantial growth from 2024 to 2031, driven by increased government initiatives to enhance healthcare, heightened health awareness among the population, and a rising demand for advanced medical technology. The region's large population and growing need for high-quality healthcare further contribute to this expected growth.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.  

Molecular Spectroscopy Market Share

The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.

Molecular Spectroscopy Market Leaders Operating in the Market Are:

• Thermo Fisher Scientific Inc. (U.S.)
• Bruker (U.S.)
• PerkinElmer (U.S.)
• Agilent Technologies, Inc. (U.S.)
• Eurofins Scientific (Luxembourg)
• Danaher Corporation (U.S.)
• Merck KGaA (Germany)
• Siemens Medical Solutions USA, Inc.
• Medtronic (Ireland)
• ABB (Switzerland)
• B&W Tek. (U.S.)
• ROBERT BOSCH TOOL CORPORATION (U.S.)
• Hamamatsu Photonics K.K. (Japan)
• HORIBA, Ltd. (Japan)
• JASCO INTERNATIONAL CO., LTD.(Japan)
• JEOL Ltd. (Japan)
• Endress+Hauser Group Services AG (Switzerland)
• Metrohm AG  (Switzerland)
• Montana Instruments Corporation. (U.S.)
• Teledyne Technologies (U.S.)
• Renishaw plc. (U.K.)
• Shimadzu Corporation (Japan)

Latest Developments in Molecular Spectroscopy Market

• In April 2023, Edinburgh Instruments unveiled its latest innovation, the IR5 benchtop FTIR Spectrometer, developed and produced at their global headquarters in Scotland. This marks the debut of the Edinburgh Instruments brand in the realm of Fourier Transform Infrared (FTIR) spectroscopy, complementing their established expertise in Raman, fluorescence, and UV-Vis absorption spectroscopies. The IR5 is a cutting-edge, high-performance FTIR instrument that offers the flexibility of being equipped with either a second detector or Fourier Transform Photoluminescence (FT-PL) capability, making it a versatile addition to their product lineup.
• 2024년 3월, 전체 의약품 수명 주기에 걸쳐 맞춤형 API 및 CDMO 서비스를 제공하는 저명한 공급업체인 LGM Pharma는 역량을 크게 강화한다고 발표했습니다. 이 회사는 분석 테스트 서비스(ATS)를 50% 확장하고 이 독립형 서비스에 200만 달러 이상을 투자하고 있습니다. 또한 LGM Pharma는 계약 개발 및 제조(CDMO) 포트폴리오에 새로운 좌약 제조 역량을 도입하고 있습니다.

SKU-1744